These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34830289)

  • 21. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
    Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
    PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE.
    Yang X; Zhang W; Chen Y; Li Y; Sun L; Liu Y; Liu M; Yu M; Li X; Han J; Duan Y
    J Biol Chem; 2016 Jul; 291(29):15108-18. PubMed ID: 27226602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term High-Fat Diet Decreases Renal Insulin-Degrading Enzyme Expression and Function by Inhibiting the PPARγ Pathway.
    Su Q; Huang J; Chen X; Wang Y; Shao M; Yan H; Chen C; Ren H; Zhang F; Ni Y; Jose PA; Zhong J; Yang J
    Mol Nutr Food Res; 2023 Apr; 67(7):e2200589. PubMed ID: 36726048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway.
    Yu H; Yang F; Zhong W; Jiang X; Zhang F; Ji X; Xue M; Qiu Y; Yu J; Hu X; Chen J; Bao Z
    Cell Signal; 2021 Aug; 84():110043. PubMed ID: 33991615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity.
    Al-Rasheed NM; Chana RS; Baines RJ; Willars GB; Brunskill NJ
    J Biol Chem; 2004 Nov; 279(48):49747-54. PubMed ID: 15375153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.
    Goto K; Iso T; Hanaoka H; Yamaguchi A; Suga T; Hattori A; Irie Y; Shinagawa Y; Matsui H; Syamsunarno MR; Matsui M; Haque A; Arai M; Kunimoto F; Yokoyama T; Endo K; Gonzalez FJ; Kurabayashi M
    J Am Heart Assoc; 2013 Jan; 2(1):e004861. PubMed ID: 23525438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice.
    Ganbaatar B; Fukuda D; Shinohara M; Yagi S; Kusunose K; Yamada H; Soeki T; Hirata KI; Sata M
    Eur J Pharmacol; 2020 May; 875():173040. PubMed ID: 32114052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empagliflozin suppresses inflammation and protects against acute septic renal injury.
    Maayah ZH; Ferdaoussi M; Takahara S; Soni S; Dyck JRB
    Inflammopharmacology; 2021 Feb; 29(1):269-279. PubMed ID: 32564182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro.
    Baer PC; Koch B; Freitag J; Schubert R; Geiger H
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.
    Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T
    J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux.
    Yamamoto T; Takabatake Y; Minami S; Sakai S; Fujimura R; Takahashi A; Namba-Hamano T; Matsuda J; Kimura T; Matsui I; Kaimori JY; Takeda H; Takahashi M; Izumi Y; Bamba T; Matsusaka T; Niimura F; Yanagita M; Isaka Y
    Autophagy; 2021 Jul; 17(7):1700-1713. PubMed ID: 32546086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.
    Xiao J; Xiang H; Xiang H; Sun Z; Xu J; Ren H; Hu P; Peng M
    Eur J Pharmacol; 2023 Dec; 960():176113. PubMed ID: 37838102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.
    Ojima A; Matsui T; Nishino Y; Nakamura N; Yamagishi S
    Horm Metab Res; 2015 Aug; 47(9):686-92. PubMed ID: 25611208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
    Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules.
    Li J; Liu H; Takagi S; Nitta K; Kitada M; Srivastava SP; Takagaki Y; Kanasaki K; Koya D
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32134397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle.
    Hu S; Yao J; Howe AA; Menke BM; Sivitz WI; Spector AA; Norris AW
    Mol Endocrinol; 2012 Jun; 26(6):977-88. PubMed ID: 22474127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
    Das NA; Carpenter AJ; Belenchia A; Aroor AR; Noda M; Siebenlist U; Chandrasekar B; DeMarco VG
    Cell Signal; 2020 Apr; 68():109506. PubMed ID: 31862399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized alkyl phospholipids stimulate sodium transport in proximal tubules via a nongenomic PPARγ-dependent pathway.
    Mizuno T; Satoh N; Horita S; Tsukada H; Takagi M; Sato Y; Kume H; Nangaku M; Nakamura M
    J Biol Chem; 2022 Mar; 298(3):101681. PubMed ID: 35124009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.